5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment

Back

ESC2025 Premium Access

5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment

Session: Secondary prevention (1)

Topic: Secondary Prevention

Speaker: Doctor P. Tonnesen (Aarhus, DK)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Pernille Tilma Tonnesen

Aarhus University Hospital, Aarhus (Denmark)

0 follower

6 more presentations in this session

Cholesterol and risk of ST-segment elevation versus non-ST-segment elevation myocardial infarction: a population-based cohort study

Speaker: Professor M. Maeng (Aarhus, DK)

Which feature of the metabolic syndrome is better predictor for coronary artery disease morbidity and mortality; a prospective 10-year analysis

Speaker: Associate Professor L. Bikdelu (Mashhad, IR)

Low dose colchicine for secondary prevention in patients with previous atherosclerotic event: a systematic review and meta-analysis of randomised trials

Speaker: Doctor R. Barbosa Sousa (Lisbon, PT)

Enhancing the precision of lipid management quality assessment in ASCVD using large language models

Speaker: Doctor D. Nguyen (Dallas, US)

Suboptimal lipid measurement and statin use after percutaneous coronary intervention according to socioeconomic status and ethnicity: a subanalysis of the DISCOVER registry

Speaker: Doctor F. Bruno (Turin, IT)

Access the full session

Secondary prevention (1)

Speakers: Doctor P. Tonnesen, Professor M. Maeng, Associate Professor L. Bikdelu, Doctor R. Barbosa Sousa, Doctor D. Nguyen...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources